ORGANON PHARMA (IRELAND) LIMITED

Organon Pharma (Ireland) Limited is an independent global healthcare company dedicated to improving the health of women throughout every stage of life. Drawing on a diverse portfolio of more than 70 medicines and medical devices, Organon delivers therapies across a wide spectrum of conditions—including reproductive health, cardiovascular disease, neurology, dermatology, autoimmune and respiratory disorders—to over 140 markets worldwide.

The company’s core specialisations fall into three pillars. In women’s health, Organon focuses on conditions that are unique to, disproportionately affect, or impact women differently, such as fertility, contraception, maternal health and vaginal health. Its biosimilar programme expands access to affordable treatment options for patients, providers and health‑care systems. In addition, Organon’s established brands span cardiovascular, respiratory, dermatology, central‑nervous‑system, bone health, immunology, non‑opioid pain management and menopause, among others.

Guided by the vision of “a better and healthier every day for every woman,” Organon combines scientific innovation with a commitment to gender equity, earning recognition for its contributions to global health and workplace inclusion.